Oct. 7, 2015 – Infondrian LLC announced receiving a $25,000 Proof of Commercial Relevance Award from Iowa Economic Development Authority.
top of page
Recent Posts
See AllAugust 10, 2020 – Infondrian released the next generation cloud-native treatment monitoring platform, ChartAlert Cloud, for beta testing at the Mount Sinai Health System (New York, NY). For the first
Sept. 10, 2019 – Infondrian LLC is pleased to announce receiving a Small Business Technology Transfer Phase II award from Department of Health and Human Services, National Institutes of Health. This t
May 25, 2018 – After 17 months of development and clinical validation, Infondrian today releases revolutionary ChartAlert V1.50 software for beta testing. University of Iowa Hospitals and Clinics and
bottom of page